(0.09%) 5 521.75 points
(0.13%) 39 894 points
(0.18%) 19 786 points
(-0.06%) $81.58
(0.68%) $2.83
(-0.24%) $2 338.70
(0.10%) $29.56
(0.43%) $1 006.10
(0.04%) $0.932
(-0.11%) $10.52
(0.00%) $0.788
(-0.85%) $87.25
-39.75% $ 0.0144
Live Chart Being Loaded With Signals
BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 1 001 |
Średni wolumen | 0 |
Kapitalizacja rynkowa | 5.46M |
EPS | $-0.0902 ( Q1 | 2024-05-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-19 | Frost Phillip Md Et Al | Sell | 129 802 | Common Stock |
2023-10-18 | Blank Andrew Scott | Buy | 12 434 | Stock Option (right to buy) |
2023-10-18 | Krasno Richard M | Buy | 12 434 | Stock Option (right to buy) |
2023-10-18 | Moyes Jay M | Buy | 12 434 | Stock Option (right to buy) |
2023-10-18 | Allen Jim L. | Buy | 12 434 | Stock Option (right to buy) |
INSIDER POWER |
---|
66.89 |
Last 98 transactions |
Buy: 2 428 811 | Sell: 421 845 |
BioCardia, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
BioCardia, Inc. Finanse
Annual | 2023 |
Przychody: | $477 000 |
Zysk brutto: | $66 000.00 (13.84 %) |
EPS: | $-0.550 |
FY | 2023 |
Przychody: | $477 000 |
Zysk brutto: | $66 000.00 (13.84 %) |
EPS: | $-0.550 |
FY | 2022 |
Przychody: | $1.35M |
Zysk brutto: | $-10.55M (-780.25 %) |
EPS: | $-0.670 |
FY | 2021 |
Przychody: | $1.02M |
Zysk brutto: | $1.02M (100.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
BioCardia, Inc.
BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej